Literature DB >> 94336

Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis.

M J Levin, C R Rinaldo, P L Leary, J A Zaia, M S Hirsch.   

Abstract

The immune response of eight patients with mononucleosis caused by cytomegalovirus (CMV) was measured early in their illness--when virus was present in their urine and/or blood--and subsequently during convalescence. Levels of CMV-specific antibody rose early in the illness, but the proliferative response of mononuclear cells to CMV antigen did not reach the level characteristic of CMV-immune donors until several months later. The production of interferon by mononuclear cells in response to CMV antigen was also low early in the illness. Although these patients had prior immunity to herpes simplex virus and varicella-zoster virus, their mononuclear cells responded poorly to antigens prepared from these viruses. The proliferative response to these antigens returned to normal in parallel with the development of a normal response to CMV. It is suggested that acute CMV mononucleosis suppresses the proliferative response of human mononuclear cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 94336     DOI: 10.1093/infdis/140.6.851

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus.

Authors:  Laura Hertel; Vashti G Lacaille; Herbert Strobl; Elizabeth D Mellins; Edward S Mocarski
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

2.  The influence of cytomegalovirus carrier status on lymphocyte subsets and natural immunity.

Authors:  J W Gratama; M Kardol; A M Naipal; J Slats; A Den Ouden; T Stijnen; J D'Amaro; T H The; J W Bruning
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

3.  Cytomegalovirus-specific cell-mediated immunity in lower-socioeconomic-class adolescent women with local cytomegalovirus infections.

Authors:  R G Faix; S E Zweig; J F Kummer; D Moore; D J Lang
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

4.  Lymphocyte subsets and natural killer cell responses during cytomegalovirus mononucleosis.

Authors:  C R Rinaldo; M Ho; W H Hamoudi; X E Gui; R L DeBiasio
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

5.  Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. I. Prolonged suppression of in vitro lymphocyte responses against CMV infected fibroblasts related to previous secondary CMV infection.

Authors:  H W Roenhorst; J M Middeldorp; J M Beelen; J Schirm; A M Tegzess; T H The
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

6.  Postnatal acquisition of primary rhesus cytomegalovirus infection is associated with prolonged virus shedding and impaired CD4+ T lymphocyte function.

Authors:  Pierre Antoine; Valerie Varner; Angela Carville; Michelle Connole; Arnaud Marchant; Amitinder Kaur
Journal:  J Infect Dis       Date:  2014-04-08       Impact factor: 5.226

7.  High levels of circulating cytomegalovirus DNA reflect visceral organ disease in viremic immunosuppressed patients other than marrow recipients.

Authors:  R L Saltzman; M R Quirk; M C Jordan
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

8.  Human cytomegalovirus productively infects primary differentiated macrophages.

Authors:  C E Ibanez; R Schrier; P Ghazal; C Wiley; J A Nelson
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

9.  Cytomegalovirus infection in infancy: virological and immunological studies.

Authors:  R C Gehrz; K M Linner; W R Christianson; A E Ohm; H H Balfour
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

10.  Modulation of natural killer cell activity in mice after interferon induction: depression of activity and depression of in vitro enhancement by interferon.

Authors:  R J Melder; M Ho
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.